NEOGENOMICS INC 8-K

What Happened

• NeoGenomics, Inc. announced on February 17, 2026 that it issued a press release reporting its fourth fiscal quarter of 2025 and full-year results for the year ended December 31, 2025. The press release is furnished as Exhibit 99.1 to the company’s Form 8-K. The filing states this information is “furnished” (not “filed”) and therefore is not subject to certain liabilities under the Securities Exchange Act.

Key Details

• Event reported: quarterly and full-year financial results (Q4 2025 and year ended Dec 31, 2025).
• Filing date: February 17, 2026.
• Exhibit included: Press Release (Exhibit 99.1).
• Form 8-K signed by Jeffrey S. Sherman, Chief Financial Officer, on behalf of NeoGenomics.

Why It Matters

• This 8-K signals that NeoGenomics has publicly released its latest earnings and financial condition information; investors should read the press release (Exhibit 99.1) for specifics on revenue, net income, EPS, segment performance, and any management commentary or guidance.
• Because the release is furnished rather than filed, it is provided for disclosure but carries different legal treatment under the Exchange Act; material financial details will also appear in subsequent periodic filings (e.g., Form 10-K) and investor materials.